Aardvark Therapeutics, Inc. Common Stock AARD Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 8.1×— | 10.6×— | 12×— | —— | —— | |
| Leverage | ||||||
| Debt-to-equity | 0×— | 0×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $3.99-65.1% | $5.43+140% | $5.64— | $6.31— | $11.42— | |
| Valuation | ||||||
| Market capitalization | $124.35M-58.6% | —— | —— | —— | —— | |
| Price / book | 1.4×-0.8× | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Aardvark Therapeutics, Inc. Common Stock's ratios come from?
- Every ratio is computed from Aardvark Therapeutics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.